J. Andrews - Concepedia

Author

J. Andrews

Also Known As

Andrews, Andrews, J M, J ANDREWS, J Andrews, J L Andrews, J. ANDREWS, J. Andrews, J.L. Andrews, JULIE ANDREWS, James W. Andrews

Publications

Citations

H-Index

102

Concepts

All Affiliations

University of Manchester Birmingham City Hospital Research Institute for Genetic and Human Therapy Procter & Gamble (United States)University of Victoria

About

J. Andrews is an author at University of Manchester specializing in medicine, pathology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	785
2	Health Sciences	7	7	297
3	Natural Sciences	4	4	106
4	Education	2	2	22
5	Engineering	1	1	51

J. Andrews

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
Tumor necrosis factor (TNF) receptor expression in T lymphocytes. Differential regulation of the type I TNF receptor during activation of resting and effector T cells Carl F. Ware, Paul D. Crowe, Todd VanArsdale, The Journal of Immunology	1991	177
Multisite kinetic models for CYP3A4: simultaneous activation and inhibition of diazepam and testosterone metabolism. Kathryn E. Kenworthy, Stephen E. Clarke, J. Andrews, PubMed Unusual KineticsExperimental PharmacologyPhysiologically-based Pharmacokinetic ModelingMolecular PharmacologyTestosterone Metabolism	2001	160
Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs A M Gallo-Penn, Pamela S. Shirley, J. Andrews, Blood	2001	111
Sustained Phenotypic Correction of Murine Hemophilia A by In Vivo Gene Therapy Sheila Connelly, J. Andrews, Angela Gallo, Blood	1998	106
Frequency and spectrum of ethylnitrosourea-induced mutation at the hprt and lacI loci in splenic lymphocytes of exposed lacI transgenic mice. Vernon E. Walker, Nancy J. Gorelick, J. Andrews, PubMed Hprt Exon 3GeneticsImmunologyPathologyMolecular Genetics	1996	87
The Use of Sonication for the Efficient Delivery of Plasmid DNA into Cells Julie Ann Wyber, J. Andrews, Antony D’Emanuele Pharmaceutical Research	1997	84
The in-vitro activity of CP 99, 219, a new naphthyridone antimicrobial agent: a comparison with fluoroquinolone agents Jenny Child, J. Andrews, F. J. Boswell, Journal of Antimicrobial Chemotherapy	1995	82
A Pragmatic Randomized Controlled Trial of Thiopurine Methyltransferase Genotyping Prior to Azathioprine Treatment: the TARGET Study William G. Newman, Katherine Payne, Karen Tricker, Pharmacogenomics	2011	73
Generation and Characterization of E1/E2a/E3/E4-Deficient Adenoviral Vectors Encoding Human Factor VIII J. Andrews, Michael J. Kadan, M Gorziglia, Molecular Therapy Transgene ExpressionImmunologyPathologyImmune SystemCancer-associated Virus	2001	66
Reducing smoking in the hospital. An effective model program. J. Andrews CHEST Journal Tobacco CessationTobacco ControlHarm ReductionHealth PolicyTobacco Use	1983	57

Page 1